11/08/2024
6:00 AM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2024
6:01 AM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2024
6:00 AM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2024
5:32 AM | KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Stengone Carmine N. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
6:02 AM | KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Shapiro Aron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
12:00 PM | KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Walters-Hoffert Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
2:45 PM | KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
TYLE PRAVEEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/15/2024
3:17 PM | KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Tosca Melissa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
6:01 AM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2024
6:01 AM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
6:02 AM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2024
2:15 PM | KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
TYLE PRAVEEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
2:15 PM | Hollander David (Reporting)
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
2:15 PM | KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Walters-Hoffert Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
2:15 PM | KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Shapiro Aron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
2:15 PM | KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Parsons Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
2:16 PM | KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Stengone Carmine N. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
2:16 PM | Daniels Eric Joseph (Reporting)
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
2:16 PM | KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Walters-Hoffert Lisa (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2024
2:16 PM | KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Tosca Melissa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
2:16 PM | KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Strem Brian M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
6:00 AM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
3:47 PM | KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Tosca Melissa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
2:40 PM | Daniels Eric Joseph (Reporting)
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
6:02 AM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2024
2:43 PM | KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
Rosalind Advisors, Inc. (Filed by)
| Form SC 13G | |
05/29/2024
2:47 PM | KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
Rosalind Advisors, Inc. (Filed by)
| Form SC 13G | |
05/10/2024
5:59 AM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/10/2024
6:00 AM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2024
6:01 AM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
11:15 PM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form EFFECT | |
03/28/2024
3:48 PM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 424B3 | |
03/25/2024
6:01 AM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/25/2024
6:03 AM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
6:00 AM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form PRE 14A | |
02/28/2024
3:40 PM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/14/2024
3:55 PM | KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
Lincoln Park Capital Fund, LLC (Filed by)
| Form SC 13G/A | |
02/13/2024
7:08 PM | KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
Lind Global Fund II LP (Filed by)
| Form SC 13G/A | |
02/12/2024
4:23 PM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2024
8:22 AM | HIRSCHMAN ORIN (Filed by)
KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
| Form SC 13G | |
02/06/2024
9:27 AM | INTRACOASTAL CAPITAL, LLC (Filed by)
KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
| Form SC 13G/A | |
DeFi Coin on Verge of Breakout! (Ad) Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin…
And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone!
I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide…
 You can get access to the report by clicking here now… |
02/01/2024
6:01 AM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
4:14 PM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/16/2024
4:16 PM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
